tiprankstipranks
Aditxt, Inc. Focuses on Growth Amid Nasdaq Compliance
PremiumCompany AnnouncementsAditxt, Inc. Focuses on Growth Amid Nasdaq Compliance
2M ago
Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
Premium
The Fly
Aditxt announces ‘positive’ FDA feedback for Appili Therapeutics ATI-1801
3M ago
Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
Premium
The Fly
Appili Therapeutics announces FDA alignment on ATI-1801 NDA requirements
3M ago
ADiTx Therapeutics trading halted, news pending
PremiumThe FlyADiTx Therapeutics trading halted, news pending
4M ago
Aditxt announces 1-for-40 reverse stock split
Premium
The Fly
Aditxt announces 1-for-40 reverse stock split
4M ago
Evofem Biosciences files proxy for stockholder approval of acquisition by Aditxt
Premium
The Fly
Evofem Biosciences files proxy for stockholder approval of acquisition by Aditxt
4M ago
Evofem signs Phexxi license agreement for Middle East with UAE’s Pharma 1
PremiumThe FlyEvofem signs Phexxi license agreement for Middle East with UAE’s Pharma 1
6M ago
Aditxt, Inc. Announces Merger and Securities Issuance Plans
Premium
Company Announcements
Aditxt, Inc. Announces Merger and Securities Issuance Plans
6M ago
Aditxt and Evofem restate merger agreement towards September 30 closing
Premium
The Fly
Aditxt and Evofem restate merger agreement towards September 30 closing
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100